Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: A single-centre study

Developmental Medicine and Child Neurology

Volumn 54, Issue 7, 2012, Pages 618-623

  Dale, Russell C ^a   Grattan Smith, Padraic ^a   Nicholson, Michelle ^a   Peters, Greg B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHOREA; CHROMOSOME; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; COPY NUMBER VARIATION; DYSKINESIA; DYSTONIA; FEMALE; GENE; GENETIC MOVEMENT DISORDER; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; MALE; MICROARRAY ANALYSIS; MOTOR DYSFUNCTION; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROXYSMAL KINESIGENIC DYSKINESIA; PAROXYSMAL NON KINESIGENIC DYSKINESIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TREMOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOREA; CHROMOSOME DELETION; DYSTONIA; DYSTONIC DISORDERS; FEMALE; GENE DELETION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOVEMENT DISORDERS; MYOCLONUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TREMOR;

EID: 84862338009     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2012.04287.x     Document Type: Article

References (17)

1. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-64.
2. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358: 667-75.
3. Grunewald A, Djarmati A, Lohmann-Hedrich K, et al. Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat 2008; 29: 331-2.
4. Devos D, Vuillaume I, De Becdelievre A, et al. New syndromic form of benign hereditary chorea is associated with a deletion of TITF-1 and PAX-9 contiguous genes. Mov Disord 2006; 21: 2237-40.
5. Muller U. The monogenic primary dystonias. Brain 2009; 132: 2005-25.
6. Dale RC, Nasti JJ, Peters GB. Familial 7q21.3 microdeletion involving epsilon-sarcoglycan causing myoclonus dystonia, cognitive impairment, and psychosis. Mov Disord 2011; 26: 1774-5.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edn). Washington, DC: American Psychiatric Association, 1994.
8. Kikuchi T, Nomura M, Tomita H, et al. Paroxysmal kinesigenic choreoathetosis (PKC): confirmation of linkage to 16p11-q21, but unsuccessful detection of mutations among 157 genes at the PKC-critical region in seven PKC families. J Hum Genet 2007; 52: 334-41.
9. Dale RC, Grattan-Smith P, Fung VSC, Peters GB. Infantile convulsions and paroxysmal kinesigenic dyskinesia with 16p11.2 microdeletion. Neurology 2011; 77: 1401-2.
10. Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011; 43: 1252-5.
11. Bonaglia MC, Marelli S, Novara F, et al. Genotype-phenotype relationship in three cases with overlapping 19p13.12 microdeletions. Eur J Hum Genet 2010; 18: 1302-9.
12. Kaminsky EB, Kaul V, Paschall J, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 2011; 13: 777-84.
13. Kearney HM, South ST, Wolff DJ, Lamb A, Hamosh A, Rao KW. American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genet Med 2011; 13: 676-9.
14. Mefford HC, Clauin S, Sharp AJ, et al. Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet 2007; 81: 1057-69.
15. Lipton J, Rivkin MJ. 16p11.2-related paroxysmal kinesigenic dyskinesia and dopa-responsive parkinsonism in a child. Neurology 2009; 73: 479-80.
16. Rosenfeld JA, Coppinger J, Bejjani BA, et al. Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications. J Neurodev Disord 2010; 2: 26-38.
17. Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010; 47: 332-41.